SCHEMBL23975633

SCHEMBL23975633

c1ccc(Nc2nc(-c3ccccn3)nc3c2CCC3)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.52
TRPV1 Q8NER1 4/20 0.52
KMT2A Q03164 3/20 0.45
METAP1 P53582 1/20 0.44
ABCG2 Q9UNQ0 4/20 0.44
ABCB1 P08183 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
USP2 O75604 1/20 0.43
POLB P06746 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
IGF1R P08069 1/20 0.42
HIF1A Q16665 1/20 0.42
TGFBR1 P36897 1/20 0.42
TGFBR2 P37173 1/20 0.42
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20665835 0.84 METAP2 (0.53) TRPV1KMT2AMETAP1KDM4ETDP1
SCHEMBL30225366 0.79 PDE4B (0.47) PDE4BKMT2AMETAP1KDM4ETDP1
SCHEMBL23976252 0.79 PDE4B (0.47) PDE4BKMT2AMETAP1KDM4ETDP1
SCHEMBL30225282 0.79 HIF1A (0.54) KMT2AKDM4EHTTSMN1; SMN2HIF1A
SCHEMBL23975681 0.79 HIF1A (0.54) KMT2AKDM4EHTTSMN1; SMN2HIF1A
Hydrochloric Acid SCHEMBL30225354 0.77 KMT2A (0.45) PDE4BTRPV1KMT2AKDM4ETDP1
SCHEMBL23986840 0.76 KDM4E (0.50) KMT2AMETAP1KDM4ETDP1POLB
SCHEMBL23975565 0.76 KDM4E (0.51) METAP1KDM4ETDP1POLBADORA3
SCHEMBL18997755 0.76 MERTK (0.52) KMT2AKDM4ETDP1HTTSMN1; SMN2
SCHEMBL20665834 0.75 TRPM8 (0.41) TRPV1KMT2AKDM4ETDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4142732-B1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2026-04-22 EP disclosed
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed